S. C. Weaver and W. K. Reisen, Present and future arboviral threats, Antivir. Res, vol.85, pp.328-373, 2010.

E. Simon-loriere, F. O. Prot, and M. , Autochthonous Japanese encephalitis with yellow fever coinfection in Africa, N. Engl. J. Med, vol.376, pp.1483-85, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-02003897

A. D. Haddow, A. J. Schuh, and C. Y. Yasuda, Genetic characterization of zika virus strains: geographic expansion of the Asian lineage, PLOS Negl. Trop. Dis, vol.6, p.1477, 2012.

A. M. Powers, A. C. Brault, R. B. Tesh, and S. C. Weaver, Re-emergence of Chikungunya and O'nyongnyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships, J. Gene. Virol, vol.81, pp.471-79, 2000.

J. E. Bryant, E. C. Holmes, and A. D. Barrett, Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas, PLOS Pathog, vol.3, p.75, 2007.

K. C. Smithburn, Neutralizing antibodies against arthropod-borne viruses in the sera of longtime residents of Malaya and Borneo, Am. J. Hyg, vol.59, pp.157-63, 1954.

N. J. Marchette, R. Garcia, and A. Rudnick, Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia, Am. J. Trop. Med. Hyg, vol.18, pp.411-426, 1969.

S. B. Halstead, Reappearance of chikungunya, formerly called dengue, Americas. Emerg. Infect. Dis, vol.21, issue.4, pp.557-61, 2015.

G. Grard, M. Caron, and I. M. Mombo, Zika virus in Gabon (Central Africa)-2007: a new threat from Aedes albopictus, vol.8, p.2681, 2014.

E. M. Leroy, D. Nkoghe, and B. Ollomo, Concurrent chikungunya and dengue virus infections during simultaneous outbreaks, Gabon, Emerg. Infect. Dis, vol.15, pp.591-93, 2007.

M. R. Duffy, T. H. Chen, and W. T. Hancock, Zika virus outbreak on Yap Island, Federated States of Micronesia, N. Engl. J. Med, vol.360, pp.2536-2579, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00734543

D. Musso and D. J. Gubler, Zika virus, Clin. Microbiol. Rev, vol.29, pp.487-524, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02004359

S. C. Weaver and N. L. Forrester, Chikungunya: evolutionary history and recent epidemic spread, Antivir. Res, vol.120, pp.32-39, 2015.

M. R. Nunes, N. R. Faria, and J. M. De-vasconcelos, Emergence and potential for spread of Chikungunya virus in Brazil, BMC Med, vol.13, p.102, 2015.

L. L. Coffey, N. Forrester, and K. Tsetsarkin, Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease, Future Microbiol, vol.8, pp.155-76, 2013.

B. D. Foy, K. C. Kobylinski, C. Foy, and J. L. , Probable non-vector-borne transmission of Zika virus, Emerg. Infect. Dis, vol.17, pp.880-82, 2011.

L. Barzon, M. Pacenti, and E. Franchin, Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, Euro Surveill, vol.21, issue.32, pp.1-4, 2016.

S. C. Weaver and M. Lecuit, Chikungunya virus and the global spread of a mosquito-borne disease, N. Engl. J. Med, vol.372, pp.1231-1270, 2015.

P. Brasil, J. P. Pereira, J. Raja-gabaglia, and C. , Zika virus infection in pregnant women in Rio de Janeiro-preliminary report, N. Engl. J. Med, vol.375, issue.24, pp.2321-2355, 2016.

E. Oehler, L. Watrin, and P. Larre, Zika virus infection complicated by Guillain-Barre syndrome-case report, Euro Surveill, vol.19, issue.9, pp.1-3, 2013.

A. C. Wielanek, J. D. Monredon, and M. E. Amrani, Guillain-Barre syndrome complicating a Chikungunya virus infection, Neurology, vol.69, pp.2105-2112, 2007.

P. Gallian, A. Cabie, and P. Richard, Zika virus in asymptomatic blood donors in Martinique, Blood, vol.129, pp.263-66, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01415646

N. Nitatpattana, K. Kanjanopas, and S. Yoksan, Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand, Virol. J, vol.11, p.183, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01083880

P. Brasil, G. A. Calvet, and A. M. Siqueira, Zika virus outbreak in Rio de Janeiro, Brazil: clinical characterization, epidemiological and virological aspects, PLOS Negl. Trop. Dis, vol.10, p.4636, 2016.

B. Parra, J. Lizarazo, and J. A. Jimenez-arango, Guillain-Barre syndrome associated with Zika virus infection in Colombia, N. Engl. J. Med, vol.375, pp.1513-1536, 2016.

R. B. Martines, J. Bhatnagar, and A. M. De-oliveira-ramos, Pathology of congenital Zika syndrome in Brazil: a case series, Lancet, vol.388, pp.898-904, 2016.

A. S. Oliveira-melo, G. Malinger, and R. Ximenes, Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg?, Ultrasound Obstet. Gynecol, vol.47, pp.6-7, 2016.

B. Miranda-filho-dde, C. M. Martelli, and R. A. Ximenes, Initial description of the presumed congenital Zika syndrome, Am. J. Public Health, vol.106, pp.598-600, 2016.

S. Cauchemez, M. Besnard, and P. Bompard, Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study, Lancet, vol.387, pp.2125-2157, 2016.

M. A. Johansson, L. Mier-y-teran-romero, and J. Reefhuis, Zika and the risk of microcephaly, N. Engl. J. Med, vol.375, pp.1-4, 2016.

M. A. Honein, A. L. Dawson, and E. E. Petersen, Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy, JAMA, vol.317, pp.59-68, 2017.

H. Tang, C. Hammack, and S. C. Ogden, Zika virus infects human cortical neural progenitors and attenuates their growth, Cell Stem Cell, vol.18, pp.587-90, 2016.

J. Mlakar, M. Korva, and N. Tul, Zika virus associated with microcephaly, N. Engl. J. Med, vol.374, issue.10, pp.951-58, 2016.

M. Culjat, S. E. Darling, and V. R. Nerurkar, Clinical and imaging findings in an infant with Zika embryopathy, Clin. Infect. Dis, vol.63, pp.805-816, 2016.

J. J. Miner and M. S. Diamond, Zika virus pathogenesis and tissue tropism, Cell Host Microbe, vol.21, pp.134-176, 2017.

R. Hamel, O. Dejarnac, and S. Wichit, Biology of Zika virus infection in human skin cells, J. Virol, vol.89, pp.8880-96, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01228435

J. M. Mansuy, E. Suberbielle, and S. Chapuy-regaud, Zika virus in semen and spermatozoa, Lancet Infect. Dis, vol.16, pp.1106-1113, 2016.

V. M. Cao-lormeau, A. Blake, and S. Mons, Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study, Lancet, vol.387, pp.1531-1570, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01453407

H. Li, L. Saucedo-cuevas, S. Shresta, and J. G. Gleeson, The neurobiology of Zika virus, Neuron, vol.92, pp.949-58, 2016.

T. Tabata, M. Petitt, and H. Puerta-guardo, Zika virus targets different primary human placental cells, suggesting two routes for vertical transmission, Cell Host Microbe, vol.20, pp.155-66, 2016.

M. A. Sheridan, D. Yunusov, and V. Balaraman, Vulnerability of primitive human placental trophoblast to Zika virus, PNAS, vol.114, pp.1587-96, 2017.

M. K. Simoni, K. A. Jurado, and V. M. Abrahams, Zika virus infection of Hofbauer cells, Am. J. Reprod. Immunol, vol.77, issue.2, pp.1-4, 2017.

T. J. Nowakowski, A. A. Pollen, D. Lullo, and E. , Expression analysis highlights AXL as a candidate Zika virus entry receptor in neural stem cells, Cell Stem Cell, vol.18, pp.591-96, 2016.

P. Hochedez, S. Jaureguiberry, and M. Debruyne, Chikungunya infection in travelers. Emerg. Infect. Dis, vol.12, pp.1565-67, 2006.

W. Taubitz, J. P. Cramer, and A. Kapaun, Chikungunya fever in travelers: clinical presentation and course, Clin. Infect. Dis, vol.45, pp.1-4, 2007.

G. Borgherini, P. Poubeau, and F. Staikowsky, Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients, Clin. Infect. Dis, vol.44, pp.1401-1408, 2007.

A. J. Rodriguez-morales, J. A. Cardona-ospina, F. Urbano-garzon, S. , S. Hurtadozapata et al., Prevalence of post-Chikungunya infection chronic inflammatory arthritis: a systematic review and meta-analysis, Arthritis Care Res, vol.68, pp.1849-58, 2016.

C. Schilte, F. Staikowsky, and T. Couderc, Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study, PLOS Negl. Trop. Dis, vol.7, p.2137, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01189712

S. P. Manimunda, D. Mavalankar, T. Bandyopadhyay, and A. P. Sugunan, Chikungunya epidemicrelated mortality, Epidemiol. Infect, vol.139, pp.1410-1422, 2011.

J. R. Torres, L. H. Falleiros-arlant, and L. Duenas, Congenital and perinatal complications of chikungunya fever: a Latin American experience, Int. J. Infect. Dis, vol.51, pp.85-88, 2016.

P. Gerardin, S. Samperiz, and D. Ramful, Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: the CHIMERE cohort study on Reunion Island, PLOS Negl. Trop. Dis, vol.8, p.2996, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01342955

T. Couderc, F. Chretien, and C. Schilte, A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease, PLOS Pathog, vol.4, p.29, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-01402310

I. Assuncao-miranda, C. Cruz-oliveira, D. Poian, and A. T. , Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis, Biomed. Res. Int, p.973516, 2013.

L. A. Silva and T. S. Dermody, Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies, J. Clin. Investig, vol.127, pp.737-786, 2017.

T. Couderc and M. Lecuit, Focus on Chikungunya pathophysiology in human and animal models, Microbes Infect. Inst. Pasteur, vol.11, pp.1197-205, 2009.

F. P. Pinheiro, R. B. Freitas, T. Da-rosa, and J. F. , An outbreak of Mayaro virus disease in Belterra, Brazil. I. Clinical and virological findings, Am. J. Trop. Med. Hyg, vol.30, pp.674-81, 1981.

E. S. Halsey, C. Siles, and C. Guevara, Mayaro virus infection, Amazon Basin region, Emerg. Infect. Dis, vol.19, pp.1839-1881, 2013.

M. Tasso-de-oliveira-mota, M. R. Ribeiro, D. Vedovello, L. Nogueira, and M. , Mayaro virus: a neglected virus of the Americas, vol.10, pp.1109-1131, 2015.

J. Ter-meulen, M. Sakho, and K. Koulemou, Activation of the cytokine network and unfavorable outcome in patients with yellow fever, J. Infect. Dis, vol.190, pp.1821-1848, 2004.

S. E. Robertson, B. P. Hull, and O. Tomori, Yellow fever: a decade of reemergence, JAMA, vol.276, pp.1157-62, 1996.

E. S. Jentes, G. Poumerol, and M. D. Gershman, The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the informal WHO working group on geographic risk for yellow fever, Lancet Infect. Dis, vol.11, pp.622-654, 2011.

C. P. Simmons, J. J. Farrar, V. V. Nguyen, and B. Wills, Dengue. N. Engl. J. Med, vol.366, pp.1423-1455, 2012.

, Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control, 2009.

K. L. Anders, N. M. Nguyet, and N. V. Chau, Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. Am, J. Trop. Med. Hyg, vol.84, pp.127-161, 2011.

T. H. Nguyen, T. L. Nguyen, and H. Y. Lei, Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever, Am. J. Trop. Med. Hyg, vol.72, pp.370-74, 2005.

C. C. Khor, T. N. Chau, and J. Pang, Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1, Nat. Genet, vol.43, pp.1139-1180, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-02069107

F. P. Pinheiro, T. Da-rosa, A. P. , T. Da-rosa, and J. F. , Oropouche virus. I. A review of clinical, epidemiological, and ecological findings, Am. J. Trop. Med. Hyg, vol.30, pp.149-60, 1981.

M. P. Mouraao, M. S. Bastos, and J. B. Gimaqu, Oropouche fever outbreak, vol.15, pp.2063-64, 2007.

B. Van-den-berg, C. Walgaard, and J. Drenthen, Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis, Nat. Rev. Neurol, vol.10, pp.469-82, 2014.

T. H. Lee, J. G. Wong, and Y. S. Leo, Potential harm of prophylactic platelet transfusion in adult dengue patients, PLOS Negl. Trop. Dis, vol.10, p.4576, 2016.

T. Couderc, N. Khandoudi, and M. Grandadam, Prophylaxis and therapy for Chikungunya virus infection, J. Infect. Dis, vol.200, pp.516-539, 2009.

E. Mastrangelo, M. Pezzullo, D. Burghgraeve, and T. , Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug, J. Antimicrob. Chemother, vol.67, pp.1884-94, 2012.

N. J. Barrows, R. K. Campos, and S. T. Powell, A screen of FDA-approved drugs for inhibitors of Zika virus infection, Cell Host Microbe, vol.20, issue.2, pp.259-70, 2016.

H. Retallack, D. Lullo, E. Arias, and C. , Zika virus cell tropism in the developing human brain and inhibition by azithromycin, PNAS, vol.113, pp.14408-14421, 2016.

G. G. Briggs, R. K. Freeman, and S. J. Yaffe, Drugs in Pregnancy and Lactation, 2008.

R. Taylor, P. Kotian, and T. Warren, BCX4430-a broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease, J. Infect. Public Health, vol.9, pp.220-246, 2016.

J. G. Julander, V. Siddharthan, and J. Evans, Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model, Antivir. Res, vol.137, pp.14-22, 2017.

L. Eyer, D. Zouharova, and J. Sirmarova, Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses, Antivir. Res, vol.142, pp.63-67, 2017.

A. Karlas, S. Berre, and T. Couderc, A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs, Nat. Commun, vol.7, p.11320, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01515939

G. Savidis, W. M. Mcdougall, and P. Meraner, Identification of Zika virus and dengue virus dependency factors using functional genomics, Cell Rep, vol.16, pp.232-278, 2016.

R. Zhang, J. J. Miner, and M. J. Gorman, A CRISPR screen defines a signal peptide processing pathway required by flaviviruses, Nature, vol.535, pp.164-68, 2016.

A. D. Barrett, Yellow fever live attenuated vaccine: a very successful live attenuated vaccine but still we have problems controlling the disease, Vaccine, vol.35, pp.5951-55, 2017.

L. J. Chang, K. A. Dowd, and F. H. Mendoza, Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial, Lancet, vol.384, pp.2046-52, 2014.

K. Ramsauer, M. Schwameis, and C. Firbas, Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebocontrolled, active-comparator, first-in-man trial, Lancet Infect. Dis, vol.15, pp.519-546, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01452896

C. J. Roy, A. P. Adams, and E. Wang, Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose, J. Infect. Dis, vol.209, pp.1891-99, 2014.

J. H. Erasmus, A. J. Auguste, and J. T. Kaelber, A chikungunya fever vaccine utilizing an insectspecific virus platform, Nat. Med, vol.23, pp.192-99, 2017.

K. A. Dowd, S. Y. Ko, and K. M. Morabito, Rapid development of a DNA vaccine for Zika virus, Science, vol.354, pp.237-277, 2016.

P. Abbink, R. A. Larocca, L. De, and R. A. Barrera, Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys, Science, vol.353, pp.1129-1161, 2016.

J. M. Richner, S. Himansu, and K. A. Dowd, Modified mRNA vaccines protect against Zika virus infection, Cell, vol.168, pp.1114-1139, 2017.

C. Shan, A. E. Muruato, and B. T. Nunes, A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models, Nat. Med, vol.23, issue.6, pp.763-67, 2017.

B. M. Forshey, C. Guevara, and V. A. Laguna-torres, Arboviral etiologies of acute febrile illnesses in Western South America, PLOS Negl. Trop. Dis, vol.4, p.787, 2000.

M. R. Capeding, M. N. Chua, and S. R. Hadinegoro, Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children, PLOS Negl. Trop. Dis, vol.7, p.2331, 2013.

S. C. Weaver, J. E. Osorio, and J. A. Livengood, Chikungunya virus and prospects for a vaccine, Expert Rev. Vaccines, vol.11, pp.1087-101, 2012.

A. Wilder-smith and T. P. Monath, Responding to the threat of urban yellow fever outbreaks, Lancet Infect. Dis, vol.17, pp.248-50, 2017.

D. Gubler and N. Vasilakis, The arboviruses-quo vadis?, Arboviruses: Molecular Biology, Evolution and Control, pp.1-6, 2016.

N. Vasilakis and S. C. Weaver, Flavivirus transmission focusing on Zika, Curr. Opin. Virol, vol.22, pp.30-35, 2017.

M. R. Wise-de-valdez, D. Nimmo, and J. Betz, Genetic elimination of dengue vector mosquitoes, PNAS, vol.108, pp.4772-75, 2011.

S. A. Ritchie, M. Townsend, and C. J. Paton, Application of wMelPop Wolbachia strain to crash local populations of Aedes aegypti, PLOS Negl. Trop. Dis, vol.9, p.3930, 2015.

T. H. Nguyen, H. L. Nguyen, and T. Y. Nguyen, Field evaluation of the establishment potential of wMelPop Wolbachia in Australia and Vietnam for dengue control, Parasites Vectors, vol.8, p.563, 2015.

E. Callaway, Rio fights Zika with biggest release yet of bacteria-infected mosquitoes, Nature, vol.539, pp.17-18, 2016.

M. T. Aliota, S. A. Peinado, I. D. Velez, and J. E. Osorio, The wMel strain of Wolbachia reduces transmission of Zika virus by Aedes aegypti, Sci. Rep, vol.6, p.28792, 2016.

M. T. Aliota, E. C. Walker, U. Yepes, and A. , The wMel strain of Wolbachia reduces transmission of chikungunya virus in Aedes aegypti, PLOS Negl. Trop. Dis, vol.10, p.4677, 2016.

R. Barrera, V. Acevedo, and G. E. Felix, Impact of autocidal gravid ovitraps on chikungunya virus incidence in Aedes aegypti (Diptera: Culicidae) in areas with and without traps, J. Med. Entomol, vol.54, pp.387-95, 2016.